Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
Argus Health
Moodys
UBS
Harvard Business School
Boehringer Ingelheim
McKinsey
Healthtrust

Generated: November 14, 2018

DrugPatentWatch Database Preview

ZEGERID OTC Drug Profile

« Back to Dashboard

Which patents cover Zegerid Otc, and when can generic versions of Zegerid Otc launch?

Zegerid Otc is a drug marketed by Bayer Healthcare Llc and is included in two NDAs.

The generic ingredient in ZEGERID OTC is omeprazole; sodium bicarbonate. There are one hundred and twenty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the omeprazole; sodium bicarbonate profile page.

Drug patent expirations by year for ZEGERID OTC
Synonyms for ZEGERID OTC
774595-73-2
Acitrel
HE387945
LS-188023
Omeprazole / sodium bicarbonate
Omeprazole mixture with sodium bicarbonate
Omeprazole, sodium bicarbonate drug combination
omeprazole/sodium bicarbonate
Rapinex
SCHEMBL2523926

US Patents and Regulatory Information for ZEGERID OTC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate CAPSULE;ORAL 022281-001 Dec 1, 2009 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 022283-001 Jun 17, 2013 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for ZEGERID OTC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 022283-001 Jun 17, 2013 ➤ Sign Up ➤ Sign Up
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate CAPSULE;ORAL 022281-001 Dec 1, 2009 ➤ Sign Up ➤ Sign Up
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate CAPSULE;ORAL 022281-001 Dec 1, 2009 ➤ Sign Up ➤ Sign Up
Bayer Healthcare Llc ZEGERID OTC omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 022283-001 Jun 17, 2013 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ZEGERID OTC
Drugname Dosage Strength RLD Date
➤ Subscribe Capsules 20 mg/1100 mg ➤ Subscribe ➤ Sign Up

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
Argus Health
Moodys
UBS
Harvard Business School
Boehringer Ingelheim
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.